Mutations in Two Genes Encoding Different Subunits of a Receptor Signaling Complex Result in an Identical Disease Phenotype
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), also known as "Nasu-Hakola disease," is a globally distributed recessively inherited disease leading to death during the 5th decade of life and is characterized by early-onset progressive dementia and bone cysts. Elsewhere, we have identified PLOSL mutations in TYROBP (DAP12), which codes for a membrane receptor component in natural-killer and myeloid cells, and also have identified genetic heterogeneity in PLOSL, with some patients carrying no mutations in TYROBP. Here we complete the molecular pathology of PLOSL by identifying TREM2 as the second PLOSL gene. TREM2 forms a receptor signaling complex with TYROBP and triggers activation of the immune responses in macrophages and dendritic cells. Patients with PLOSL have no defects in cell-mediated immunity, suggesting a remarkable capacity of the human immune system to compensate for the inactive TYROBP-mediated activation pathway. Our data imply that the TYROBP-mediated signaling pathway plays a significant role in human brain and bone tissue and provide an interesting example of how mutations in two different subunits of a multisubunit receptor complex result in an identical human disease phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Homozygous loss-of-function mutations in TREM2 or DAP12 genes cause Nasu–Hakola disease (NHD), a rare genetic disorder characterized by fatal presenile dementia and bone cysts [38, 39].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [39]
In the citing paper
“TYROBP is a transmembrane adaptor protein for TREM2, SIRPβ1, and CR3 receptors, which are known to be involved in AD pathogenesis [90–92].”
From Sex-specific DNA methylation differences in Alzheimer’s disease pathology (2021) · cites this paper as [92]
In the citing paper
“Homozygous Q33X, Y38C and T66M variants have been identified in patients with Nasu-Hakola disease [44, 47, 95].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [95]
In the citing paper
“A number of mutations in PLCG2 (about 75%), that have been previously implicated in various inflammatory diseases [92–102], actually map to the autoinhibitory interface on the PLCγ2 model structure and can be considered as pathogenic (Fig. 2c)”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [95]
In the citing paper
“Even more rare loss-of-function mutations of TREM2 or DAP12 cause a form of recessively inherited presenile dementia, called Nasu-Hakola disease (126, 127).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [126]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Bouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284 · cited 4×
“2001a), whereas TREM2 is expressed on macrophages and monocyte-derived dendritic cells, suggesting that TREM2 plays a role in chronic, rather than in acute, inflammation (Bouchon et al. 2000).”
BackgroundInfluentialTREM-1 amplifies inflammation and is a crucial mediator of septic shock
Bouchon, A., Facchetti, F., Weigand, M. A., & Colonna, M. (2001) · Nature · doi:10.1038/35074114 · Cited by 1,090 · cited 2×
“TREM1 is strongly up-regulated in cells that mediate acute inflammatory responses to bacterial infection (i.e., neutrophils and monocytes) (Bouchon et al. 2001a), whereas TREM2 is expressed on macrophages and monocyte-derived dendritic cells, suggesting that TREM2 plays a role in chronic, rather…”
BackgroundImmunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
Lanier, L. L., Corliss, B. C., Wu, J., Leong, C., & Phillips, J. H. (1998) · Nature · doi:10.1038/35642 · Cited by 904 · cited 5×
“This has been shown to disrupt the association with (McVicar et al. 1998; Bakker et al. 1999), as well as the cell-surface expression of, TYROBP (Lanier et al. 1998b; Smith et al. 1998).”
BackgroundInfluentialVitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748 · cited 1×
“1) (Vitale et al. 1998), MDL1 (chromosome 7q33) (Bakker et al. 1999), CD94 (chromosome 12p13.”
Association of DAP12 with Activating CD94/NKG2C NK Cell Receptors
Lanier, L. L., Corliss, B., Wu, J., & Phillips, J. H. (1998) · Immunity · doi:10.1016/s1074-7613(00)80574-9 · Cited by 559 · cited 5×
“This has been shown to disrupt the association with (McVicar et al. 1998; Bakker et al. 1999), as well as the cell-surface expression of, TYROBP (Lanier et al. 1998b; Smith et al. 1998).”
BackgroundInfluentialLoss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts
Paloneva, J., Kestilä, M., Wu, J., Salminen, A., Böhling, T., Ruotsalainen, V., Hakola, P., Bakker, A. B. H., Phillips, J. H., Pekkarinen, P., et al. (2000) · Nature Genetics · doi:10.1038/77153 · Cited by 460 · cited 6×
“Interestingly, patients with PLOSL who are homozygous for mutations in either TREM2 or TYROBP display identical CNS and bone manifestations (table 2)—and no immunological symptoms (Paloneva et al. 2000).”
BackgroundInfluentialSelf-citationBouchon, A., Hernández-Munain, C., Cella, M., & Colonna, M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1111 · Cited by 460 · cited 2×
“TREM1 is strongly up-regulated in cells that mediate acute inflammatory responses to bacterial infection (i.e., neutrophils and monocytes) (Bouchon et al. 2001a), whereas TREM2 is expressed on macrophages and monocyte-derived dendritic cells, suggesting that TREM2 plays a role in chronic, rather…”
BackgroundLy-49D and Ly-49H associate with mouse DAP12 and form activating receptors.
Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H., & Lanier, L. L. (1998) · PubMed · Cited by 277
Cutting Edge: Ly-49D and Ly-49H Associate with Mouse DAP12 and Form Activating Receptors
Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H., & Lanier, L. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.7 · Cited by 249 · cited 1×
“This has been shown to disrupt the association with (McVicar et al. 1998; Bakker et al. 1999), as well as the cell-surface expression of, TYROBP (Lanier et al. 1998b; Smith et al. 1998).”
BackgroundMutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are associated with holoprosencephaly
Ming, J. E., Kaupas, M. E., Roessler, E., Brunner, H. G., Golabi, M., Tekin, M., Stratton, R. F., Sujansky, E., Bale, S. J., & Muenke, M. (2002) · Human Genetics · doi:10.1007/s00439-002-0695-5 · Cited by 244
CNS manifestations of Nasu–Hakola disease: A frontal dementia with bone cysts
Paloneva BM, J., Autti, T., Raininko, R., Partanen, J., Salonen, O., Puranen, M., Hakola, P., & Haltia, M. (2001) · Neurology · doi:10.1212/wnl.56.11.1552 · Cited by 211
DAP12-mediated Signal Transduction in Natural Killer Cells
McVicar, D. W., Taylor, L. S., Gosselin, P., Willette-Brown, J., Mikhael, A. I., Geahlen, R. L., Nakamura, M. C., Linnemeyer, P., Seaman, W. E., Anderson, S. K., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32934 · Cited by 211 · cited 3×
“This has been shown to disrupt the association with (McVicar et al. 1998; Bakker et al. 1999), as well as the cell-surface expression of, TYROBP (Lanier et al. 1998b; Smith et al. 1998).”
BackgroundBakker, A. B. H., Baker, E., Sutherland, G. R., Phillips, J. H., & Lanier, L. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9792 · Cited by 210 · cited 4×
“1) (Vitale et al. 1998), MDL1 (chromosome 7q33) (Bakker et al. 1999), CD94 (chromosome 12p13.”
BackgroundInfluentialThe ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function
Lanier, L. L., & Bakker, A. B. H. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01745-x · Cited by 202 · cited 2×
“Phosphorylated ITAM binds the cytosolic PTKs SYK and ZAP70, and this interaction leads to an increase in intracellular Ca(2) concentration and to subsequent cellular activation (Lanier and Bakker 2000).”
BackgroundNasu, T., Tsukahara, Y., & Terayama, K. (1973) · Acta Pathologica Japonica · doi:10.1111/j.1440-1827.1973.tb01223.x · Cited by 185 · cited 1×
“…on the cell type, we used a genetic approach to search for genes involved in polycystic lipomembranousosteodysplasiawith sclerosing leukoencephalopathy (PLOSL [MIM 221770]), also known as “Nasu-Hakola disease” (Nasu et al. 1973; Paloneva et al. 2001; also see the GeneTests–GeneClinics Web site).”
MethodDietrich, J., Cella, M., Seiffert, M., Bühring, H.-J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.9 · Cited by 172 · cited 1×
“These genes included those for TYROBP-associated receptors SIRPBETA1 (chromosome 20p13) (Dietrich et al. 2000), TREM1 (chromosome 6p21.”
BackgroundA Susceptibility Locus for Migraine with Aura, on Chromosome 4q24
Wessman, M., Kallela, M., Kaunisto, M. A., Marttila, P., Sobel, E., Hartiala, J., Oswell, G., Leal, S. M., Papp, J. C., Hämäläinen, E., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339078 · Cited by 171 · cited 1×
“Genotyping was performed as described elsewhere (Wessman et al. 2002).”
Self-citationHakola, H. P. (1972) · PubMed · Cited by 159
Bird, T. D., Koerker, R. M., Leaird, B. J., Vlcek, B. W., & Thorning, D. R. (1983) · Neurology · doi:10.1212/wnl.33.1.81 · Cited by 65 · cited 1×
“Since our sequence analyses of TYROBP from one American (whose family originates from Slovakia [Bird et al. 1983]), from one Bolivian, and from two Italian sibs, all of whom have PLOSL, had not revealed mutations, we amplified and sequenced the exons and intronexon boundaries of TREM2 from the…”
BackgroundSelf-citationDAP12: a key accessory protein for relaying signals by Natural Killer cell receptors
Campbell, K. S., & Colonna, M. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00022-9 · Cited by 56 · cited 2×
“of macrophages and dendritic cells, TREM2 is bound noncovalently to a disulfide-bonded TYROBP homodimer (Campbell and Colonna 1999; Bouchon et al. 2001b).”
BackgroundAssignment of the Locus for PLO-SL, a Frontal-Lobe Dementia with Bone Cysts, to 19q13
Pekkarinen, P., Hovatta, I., Hakola, P., JÄRVI, O. H., Kestilä, M., Lenkkeri, U., Adolfsson, R., Holmgren, G., Nylander, P., Tranebjærg, L., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301722 · Cited by 50 · cited 2×
“1 (Pekkarinen et al. 1998a, 1998b), Received May 6, 2002; accepted for publication June 11, 2002; electronically published June 21, 2002.”
BackgroundSelf-citationKim, K. J., Kotake, S., Udagawa, N., Ida, H., Ishii, M., Takei, I., Kubo, T., & Takagi, M. (2001) · Journal of Biomedical Materials Research · doi:10.1002/jbm.1033 · Cited by 32 · cited 1×
“With these inductors, multinuclear tartrate-resistant acid phosphatase– and cathepsin K–positive osteoclastic cells can be generated from peripheral blood monocytes (Kim et al. 2001).”
BackgroundHakola, H. P. A., & Puranen, M. (1993) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb05360.x · Cited by 30
Fine-Scale Mapping of a Novel Dementia Gene, PLOSL, by Linkage Disequilibrium
Pekkarinen, P., Kestilä, M., Paloneva, J., Terwilliger, J., Varilo, T., Järvi, O., Hakola, P., & Peltonen, L. (1998) · Genomics · doi:10.1006/geno.1998.5591 · Cited by 26 · cited 2×
“1 (Pekkarinen et al. 1998a, 1998b), Received May 6, 2002; accepted for publication June 11, 2002; electronically published June 21, 2002.”
BackgroundSelf-citationHakola, H. P., & Partanen, V. S. J. (1983) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.46.6.515 · Cited by 22
Lipomembranous osteodysplasia: A case report
Edvardsen, P., Halvorsen, T. B., & Nesse, O. (1983) · International Orthopaedics · doi:10.1007/bf00266458 · Cited by 14 · cited 5×
“1996) and Norway (Edvardsen et al. 1983), and each had two affected family members (Pekkarinen et al.”
BackgroundInfluentialNylander, P.-O., Drugge, U., Holmgren, G., & Adolfsson, R. (1996) · Clinical Genetics · doi:10.1111/j.1399-0004.1996.tb02387.x · Cited by 10
Self-citationTranebjaerg, L., Schrader, H., & Paloneva, J. (2000) · PubMed · Cited by 5
Self-citationDaws (2001) · doi:10.1002/1521-4141(200103)31:3<783::aid-immu783>3.0.co;2-u · cited 2×
“TREM2 polypeptide has a structure similar to that of TYROBP-associated TREM1 and LY95, these proteins constituting a superfamily of activating cell-surface receptors (Daws et al. 2001).”
Background
Research works printed but not linked: 1
- Tranebjærg, 2000, Polycystic lipomembranous osteodysplasia, Tidsskr Nor Laegeforen, 120, 3196
Cited by
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
Inflammation as a central mechanism in Alzheimer's disease
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253
“[138] Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, Adolfsson R, et al.”
BackgroundMicroglia in Alzheimer’s disease
Hansen, D. V., Hanson, J. E., & Sheng, M. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709069 · Cited by 1,935
Metadata
- Authors
- Paloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., Tranebjærg, L., Konttinen, Y., & Peltonen, L.
- Affiliations
- University of Helsinki (FI)
- University of California, Los Angeles (US)
- Umeå University (SE)
- University of Washington (US)
- Hospital Universitario La Paz (ES)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- Bispebjerg Hospital (DK)
- Helsinki University Hospital (FI)
- Corresponding author
- Peltonen, Leena
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-09
- Volume
- 71
- Issue
- 3
- Pages
- 656-662
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC379202
- OpenAlex
- W2014200126
- Cited by
- 683
- References
- 29
- Citations by year
- 2026: 28 · 2025: 32 · 2024: 27 · 2023: 35 · 2022: 37 · 2021: 48 · 2020: 47 · 2019: 34 · 2018: 54 · 2017: 53 · 2016: 38 · 2015: 42 · 2014: 29 · 2013: 28 · 2012: 11
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3974 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Lastentautien Tutkimussäätiö
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Nasu-Hakola disease, TREM2, TYROBP, DAP12, receptor signaling complex, genetic heterogeneity, progressive dementia, bone cysts, recessive inheritance
- MeSH terms
- Triggering Receptor Expressed on Myeloid Cells-1, Actins, Female, Haplotypes, Humans, Male, Membrane Glycoproteins, Membrane Proteins, Molecular Sequence Data, Mutation, Pedigree, Phenotype, Receptors, Immunologic, RNA, Messenger, Signal Transduction, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Protein Subunits, Macromolecular Substances, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.